These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28807926)

  • 1. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
    Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis.
    Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
    Cancer Res; 2017 Nov; 77(21):6033-6041. PubMed ID: 28935814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
    Boudreau DM; Yu O; Chubak J; Wirtz HS; Bowles EJ; Fujii M; Buist DS
    Breast Cancer Res Treat; 2014 Apr; 144(2):405-16. PubMed ID: 24557337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis.
    Balkrishnan R; Desai RP; Narayan A; Camacho FT; Flausino LE; Chammas R
    Cancer Med; 2021 Aug; 10(15):5347-5357. PubMed ID: 34184420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and outcomes following early-stage breast cancer.
    Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
    Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
    Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
    Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between diabetes medication use and risk of second breast cancer events and mortality.
    Calip GS; Yu O; Hoskins KF; Boudreau DM
    Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer.
    Chen L; Malone KE; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1423-6. PubMed ID: 26084603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer.
    Lorona NC; Cook LS; Tang MC; Hill DA; Wiggins CL; Li CI
    Cancer Causes Control; 2021 Dec; 32(12):1375-1384. PubMed ID: 34347212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent antibiotic use and second breast cancer events.
    Wirtz HS; Buist DS; Gralow JR; Barlow WE; Gray S; Chubak J; Yu O; Bowles EJ; Fujii M; Boudreau DM
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1588-99. PubMed ID: 23833124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography use, breast cancer stage at diagnosis, and survival among older women.
    McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
    J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.
    Harding BN; Delaney JA; Urban RR; Weiss NS
    Gynecol Oncol; 2019 Aug; 154(2):426-431. PubMed ID: 31178150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
    Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
    Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.
    Ganz PA; Habel LA; Weltzien EK; Caan BJ; Cole SW
    Breast Cancer Res Treat; 2011 Sep; 129(2):549-56. PubMed ID: 21479924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer.
    van la Parra RFD; Liao K; Smith BD; Yang WT; Leung JWT; Giordano SH; Kuerer HM
    JAMA Surg; 2018 Jun; 153(6):559-568. PubMed ID: 29387884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
    Holmes S; Griffith EJ; Musto G; Minuk GY
    Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second breast cancer events with chronic opioid use in breast cancer survivors.
    Boudreau DM; Chen L; Yu O; Bowles EJA; Chubak J
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):740-753. PubMed ID: 30945381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of death and relative survival of older women after a breast cancer diagnosis.
    Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
    J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up.
    Kim SA; Moon H; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Clin Transl Oncol; 2017 Jul; 19(7):826-833. PubMed ID: 28093700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.